Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.
about
Enhancing oral vaccine potency by targeting intestinal M cellsPrime-boost approaches to tuberculosis vaccine developmentDistribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in miceGeneration of female genital tract antibody responses by local or central (common) mucosal immunizationSystemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humansRoute of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humansSpecific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroBidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell lineInhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.Vaccination strategies for mucosal immune responsesOptimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions.Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.Induction and distribution of intestinal immune responses after administration of recombinant cholera toxin B subunit in the ileal pouches of colectomized patients.Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humansNasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginallyMaternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.Current progress in the development of a prophylactic vaccine for HIV-1.Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.Cervico-vaginal immunoglobulin G levels increase post-ovulation independently of neutrophils.Protein-coated nanoparticles are internalized by the epithelial cells of the female reproductive tract and induce systemic and mucosal immune responses.Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cellsNeonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteriaActivation of B cells by a dendritic cell-targeted oral vaccine.Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage formsIntranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma.Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.
P2860
Q21089613-9A4E4C25-E198-4E0C-868B-D2B740EE6D0FQ27024526-2366DD2E-D8BC-47F9-BF44-8CDB69516B06Q28477998-1FB2FCAB-FC6F-4B85-8159-F9E8DBB0262FQ33591251-FA89A309-CD06-4C28-A024-842280C885A7Q33592158-8D084727-628C-4326-A5A2-E5D3BE16B769Q33716593-BE13A0B5-8643-4311-89D2-730DA9293823Q33756767-6A0FE0C6-3BE6-496A-AF6E-D1B91433E001Q33760450-A33A37C8-FD83-4A3C-B4D5-EB9F92A1BF47Q33768258-B413E184-A790-4C7E-8AF1-0B4C3DB5514DQ33769451-AEC38D55-E64F-4283-BD3E-FF4CBF0D4039Q33784161-D20657B2-08DB-40AB-B083-3520CC3A11DFQ33853775-50916DB0-AD87-4843-A2D3-41271471937CQ33858496-8848DA1D-FE9D-462E-BA00-A5CBBF3B2CCFQ33897480-E032D1AC-300F-46BD-A783-9ADDD3F47AD8Q33975703-CB3F5FBE-69D7-4649-919B-9CC87ADD3C94Q33998104-DF5DEBA1-BA3B-4597-ADC7-1CFCA3CF412BQ34000146-4AE2F706-6C30-4FD5-8792-FE420DC007F8Q34001388-118DFA34-FB1E-4499-80E3-41230F1BCC77Q34007446-19ABDD21-45D3-4AA7-B411-77947557F4DFQ34008126-F3791B5B-FA2B-49FB-9AE3-3A15A677CA74Q34009698-48C7E61A-7950-4559-9990-23720B355172Q34044915-B0F83413-C7F0-48E1-A3EA-1A0D61A194ABQ34193265-9CDEEA73-22DB-4CFE-AD3C-A35BC04FAE3AQ34429327-8E0F99FB-62E5-4E6D-B429-8EFA688C8F76Q34502108-4EAF861B-629E-4CEF-B882-BF526D4FED95Q34545847-8285289B-0EBB-4FDD-80F3-402DC1AC68BBQ34598141-06609CA4-FE58-445E-A96B-F468EA867C18Q34640774-FE38E2B0-AD81-4E48-89D1-DE7461922F1FQ34663077-979923E8-1CCC-49A0-93FE-BA538CD89995Q34693822-8BBB725D-62D5-44EC-A68F-AA810E23CCABQ34717658-2A1B92F4-98C4-4568-93AA-CA41AE8AFBD2Q34768249-03EB9E58-DCF6-47A8-8C99-FD09E2BF880DQ34979404-5AC1E81E-D279-474C-BF23-06EEABDEDDF2Q35019917-02AA072E-FD99-4F14-A73B-33A363C7E245Q35061979-28E7F9A9-DAD9-41EB-B5CF-3BF710317590Q35066276-BF6FA2E4-87FD-45F5-897A-AF791D418EBBQ35575565-EBC3FD80-B5B6-4806-9EC4-C5BFA98CDF15Q35577620-4AA6DF8B-57F2-440D-A3F8-6F7A2C8E16C9Q35581949-894EAF70-FB21-4727-B65A-5A2905CC49AAQ35675933-F91906C2-6542-42A1-A221-914D9F03BBF6
P2860
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Comparison of the oral, rectal ...... tal tract secretions of women.
@ast
Comparison of the oral, rectal ...... tal tract secretions of women.
@en
type
label
Comparison of the oral, rectal ...... tal tract secretions of women.
@ast
Comparison of the oral, rectal ...... tal tract secretions of women.
@en
prefLabel
Comparison of the oral, rectal ...... tal tract secretions of women.
@ast
Comparison of the oral, rectal ...... tal tract secretions of women.
@en
P2093
P2860
P1476
Comparison of the oral, rectal ...... tal tract secretions of women.
@en
P2093
M R Neutra
P A Kozlowski
T P Flanigan
P2860
P304
P407
P577
1997-04-01T00:00:00Z